DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/69mrxk/depression_market) has announced the addition of the "Depression Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014" report to their offering.
Depression Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India.
The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.
Key Topics Covered:
- Indication Overview
- Marketed Drugs Assessment
- Marketed Details of Drugs by Application Type
- Marketed Details of Drugs (NDA) by Marketing Status
- Marketed Details of Drugs by Patent Expiration Timeline
- The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
- The API Manufacturers by the United States Drug Master File (US DMF) Status
- The API Manufacturers by the US DMF Status (Drug Specific)
- The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
- The API Manufacturers by the US DMF Status (Drug Specific)
- Drugs Market Data and Forecasted Sales Figures (2011-2015)
- Marketed Drugs Information
- Drugs Description
- Route of Synthesis
- Global Active Pharmaceutical Manufacturers
- Approval Status
- Patent and Exclusivity Details
- Company Overview
- Phase III Drugs Information
- Phase III Drugs Description
- The United States Drug Master Filings (US DMF)
- Discontinued Drugs Information
Companies Mentioned
- Forest Laboratories, Inc.
- Pfizer Inc.
- Abbott Laboratories
- Sanofi
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- sanofi-aventis U.S. LLC.
- Validus Pharmaceuticals LLC
- AstraZeneca PLC
- Valeant Pharmaceuticals International, Inc.
- Teva Pharmaceutical Industries Limited
- Lilly USA, LLC
- Janssen Pharmaceutical Ltd
- Merck & Co., Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Teva Pharmaceuticals USA, Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd.
- AstraZeneca Pharmaceuticals, LP
- Baxter Healthcare Corporation
- GlaxoSmithKline LLC
- Solvay Pharmaceuticals, Inc.
- Roxane Laboratories, Inc.
- Bayer HealthCare Pharmaceuticals Inc.
- Solvay Pharma Inc.
- New River Pharmaceuticals, Inc.
- GlaxoSmithKline plc
- Bioniche Pharma Group Limited
- Dr. Reddy's Laboratories Limited
- Orchid Chemicals & Pharmaceuticals Ltd
For more information visit http://www.researchandmarkets.com/research/69mrxk/depression_market